Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Can rice bran oil melt away cholesterol?

12.05.2005


A natural component of rice bran oil lowers cholesterol in rats, and ongoing research also shows it may have potential as an anti-cancer and anti-infection agent in humans, according to a University of Rochester scientist who has studied the antioxidant since 1996.



The latest findings from Mohammad Minhajuddin, Ph.D., and colleagues, are reported in the May 2005 Food and Chemical Toxicology journal. They show that total cholesterol levels in animals dropped by 42 percent, and LDL or "bad cholesterol" levels dropped up to 62 percent, after their diets were supplemented with a concentrated form of Vitamin E called tocotrienol rich fraction or TRF isolated from rice bran oil.

Vitamin E, which has been widely studied for its health benefits, consists of both tocopherols and tocotrienols. Much research has focused on the tocopherols derived from corn, wheat and soybean. But the tocotrienols (TRF) seem to have greater antioxidant properties and are becoming more noteworthy in scientific research, Minhajuddin says. TRF is derived from barley, oats, palm and rice bran.


The best form of TRF comes from rice bran oil, which is contained in the outer grain hull of rice. Its properties inhibit the activity of HMG-CoA reductase, an enzyme involved in cholesterol biosynthesis. However, since taking any form of Vitamin E for a long time can be harmful, the purpose of Minhajuddin’s latest reported research was to find the minimum dose of TRF that provided the maximum antioxidants and effectively lowered cholesterol.

The results: The most effective dose in rats was 8 IU kg/day. Extrapolated to humans, a person with an average body weight of 154 pounds would get around 560 IU, which is close to the 400 IU of Vitamin E normally taken. (The upper tolerable intake of Vitamin E is 1500 IU).

Researchers have been investigating natural ways (besides diet and exercise) to achieve lower cholesterol levels, despite the popularity and effectiveness of statin drugs. Although millions of Americans take statins and do well, they are expensive and they come with side effects. So far, scientists have not found any adverse effects of tocotrienols, says Minhajuddin, a research associate in the Department of Pediatrics.

Minhajuddin, who is from India, also has preliminary, unpublished data from a study he conducted in that country, showing that TRF reduces cholesterol in humans as well as in animals. Five healthy volunteers with total cholesterol levels in the "normal" range of 170-230 mg/dL, who ingested TRF in capsule form at a dose of 8 IU kg/day for four weeks, saw their cholesterol levels drop by 10 percent with a 26-percent decline in LDL-cholesterol levels. A case study of a 5-year-old boy in India, who had a genetic defect (familial hypercholesterolemia) that caused his total cholesterol to climb to 440 mg/dL, resulted in a 20-percent decline after about two months of tocotrienol supplements. The boy’s cholesterol did rise again, however, after 100 weeks of TRF supplements.

In addition, Minhajuddin and colleagues previously showed in animals that TRF reacts with liver enzymes in such a way that it clears toxic substances from the organ, and reduces or stabilizes liver tumors. The group concluded that long-term use of tocotrienol might reduce overall cancer risk, according to published research last year in the European Journal of Cancer Prevention. Currently, Minhajuddin’s research group is using a scientific model to study infection and the immune system, and how to regulate the expression of a gene called ICAM-1 on the surface of endothelial cells.

Leslie Orr | EurekAlert!
Further information:
http://www.urmc.rochester.edu

More articles from Studies and Analyses:

nachricht The personality factor: How to foster the sharing of research data
06.09.2017 | ZBW – Leibniz-Informationszentrum Wirtschaft

nachricht Europe’s Demographic Future. Where the Regions Are Heading after a Decade of Crises
10.08.2017 | Berlin-Institut für Bevölkerung und Entwicklung

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: The pyrenoid is a carbon-fixing liquid droplet

Plants and algae use the enzyme Rubisco to fix carbon dioxide, removing it from the atmosphere and converting it into biomass. Algae have figured out a way to increase the efficiency of carbon fixation. They gather most of their Rubisco into a ball-shaped microcompartment called the pyrenoid, which they flood with a high local concentration of carbon dioxide. A team of scientists at Princeton University, the Carnegie Institution for Science, Stanford University and the Max Plank Institute of Biochemistry have unravelled the mysteries of how the pyrenoid is assembled. These insights can help to engineer crops that remove more carbon dioxide from the atmosphere while producing more food.

A warming planet

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Rainbow colors reveal cell history: Uncovering β-cell heterogeneity

22.09.2017 | Life Sciences

Penn first in world to treat patient with new radiation technology

22.09.2017 | Medical Engineering

Calculating quietness

22.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>